Apimeds Pharmaceuticals US, Inc. (APUS) has filed a Form NT 10-Q with the SEC, indicating a delay in its quarterly report submission. The company is seeking a five-day extension to complete the filing.
Apimeds Files Notice for Delayed 10-Q, Seeks Five-Day Extension
APUSSEC Filing10-QRegulatory ComplianceBiotech

